J-Star
Japan’s J-Star sees 3x return on Apo Plus Station
Mid-market Japanese GP J-Star has sold its majority stake in the pharma-focused contract sales company Apo Plus Station (APS) to Qol, a Tokyo-based pharmaceutical firm.
Japan fundraising: Talk isn’t cheap
Japan’s mid-market GPs must overcome perception issues and limited internal resources if they are to raise capital in a challenging market. Effective communication is the key
Japan GP outlook: Mixed feelings in the middle ground
Japan’s mid-market is opening up as weak public market valuations facilitate take-private deals, corporations divest non-core assets and aging founders seek an exit. GPs have plenty to aim at, provided they can raise funds
Japan’s J-Star exits Iki Iki to Noritsu Koki Group
J-Star, the mid-market Japanese GP, has exited lifestyle marketing company Iki Iki to a subsidiary of Noritsu Koki Group. The transaction is expected to close on September 7.